the purpose of this study, all collected specimens underwent treponemal testing regardless of the nontreponemal test result. The SHC result was compared with results of routine syphilis testing using the traditional testing algorithm at the state laboratory. Sensitivity, specificity, and overall laboratory test agreement were determined using the Trep-Sure qualitative enzyme immunoassay (EIA) reference treponemal test as the standard for "true" positive or negative treponemal test results.
The SHC was used to screen 202 patients for syphilis. Among these patients, 171 (85%) were nonreactive on all syphilis tests (SHC, EIA, and RPR), 26 (13%) had a reactive SHC, and five (2%) had a nonreactive SHC but had one or more reactive tests at the state laboratory. Among the 26 reactive SHCs, 10 (38%) had a reactive EIA (six had a reactive RPR), and 16 (62%) were not confirmed by EIA or RPR at the state laboratory. For the six reactive SHC patients with reactive EIA and reactive RPR, three were staged as secondary syphilis, one as primary syphilis, one as early latent syphilis, and one was a previously treated positive with no increase in titer since last testing. Among the five specimens that were reactive on other tests but SHC nonreactive, only one was both RPR (1:8 serum dilution) and EIA reactive. It came from a patient with primary syphilis and a history of herpes simplex virus 2, and a reactive RPR (1:2 serum dilution) that was collected 6 days before the SHC test.
The sensitivity of SHC was 71.4% (95% confidence interval [CI] = 41.9%-95.1%) when compared with the Trep-Sure (EIA) reference treponemal test (Table) . The specificity of the SHC compared with the reference treponemal test was 91.5% (95% CI = 87.5%-95.5%).
The findings in this study are subject to at least one limitation. The sample size was 202; however, results indicate a high proportion of reactive SHC tests were not confirmed by reference treponemal testing (16 of 26, 61.5%). This relatively low positive predictive value suggests that reactive SHC results should be interpreted with caution. Furthermore, four of 14 specimens that tested positive on the reference treponemal test tested negative on the SHC, including one from a patient with primary syphilis. Sensitivity and specificity analyses of the SHC using fingerstick specimens at the Florida Department of Health in Escambia County's STD clinic were significantly lower than the >98% reported by the manufacturer of SHC in a 510(k) submission (3) . Further evaluation of the sensitivity and specificity of the SHC in additional health care settings is needed to determine whether SHC might be beneficial in identifying patients who might have syphilis, especially in settings where phlebotomy is unavailable. Abbreviations: CI = confidence interval; EIA = enzyme immunoassay; STD = sexually transmitted disease. * Sensitivity and specificity were calculated comparing the results of the Syphilis Health Check against the reference treponemal tests used at the state public health laboratory in Florida.
